Partnerships & Joint Ventures
-
Congenica enters into cancer collaboration with Glasgow University spin-out
Cambridge digital health business Congenica is collaborating with Gabriel Precision Oncology – a spin-out from Glasgow University – on a novel cancer... Read More
-
Medovate and Konica Minolta in US promote best practice in anaesthesia
Cambridge MedTech innovator Medovate has teamed up with Konica Minolta Healthcare Americas, Inc. to promote best practice within regional anaesthesia... Read More
-
UK-US alliance explores gene therapies to avert blindness
Gyroscope Therapeutics in Stevenage and the University of Pennsylvania have joined forces to develop novel gene therapies to counter serious eye... Read More
-
Antibody deal involves Cambridge, Portugal and US
FairJourney Biologics in Portugal and Cambridge’s IONTAS, which joined forces in May, have entered an antibody discovery agreement with Pandion... Read More
-
Repositive expands CRO network with Pharmatest partnership
Cambridge-based Repositive, which claims “the world’s largest directory of preclinical cancer models,” has expanded its global network of contract... Read More
-
New Oxbridge alliance to develop next-generation CAR-T cell therapies
PhoreMost, the Cambridge biopharma company dedicated to developing drugs against intractable disease targets, has entered into a discovery... Read More
-
Bango and Microsoft unite to boost new Xbox cloud gaming subscriptions
Cambridge mobile payment technology world leader Bango has reinforced its partnership with Microsoft to open-up access to Xbox subscriptions and... Read More
-
Sosei Heptares cashes in on new Cambridge-California business enterprise
Cambridge-based Sosei Heptares and Aditum Bio in California have created a new company – Tempero Bio – to advance the clinical development of the... Read More
-
Cambridge-Sydney alliance advances promising cancer immunotherapy
Biosceptre in Cambridge UK has teamed up with Australian cancer tech trailblazer Carina Biotech to advance a promising oncology immunotherapy.... Read More
-
Cambridge-Swiss alliance produces new microfluidic driver
Cambridge micropump manufacturer TTP Ventus has revealed a UK-Swiss technology alliance to create a compact high-performance microfluidic driver. TTP... Read More
-
Perfect STORM as partners explore role of RNA epigenetics in epilepsy
STORM Therapeutics in Cambridge and Dublin based FutureNeuro have joined forces to explore new treatment options for people with epilepsy.... Read More
-
Crescendo enters collaboration to create cutting-edge oncology treatment
Cambridge-based Crescendo Biologics Ltd, the drug developer of novel, targeted T cell enhancing therapeutics has signed a pre-clinical collaboration... Read More
-
Medical alliance to advance technology push
Plextek Services and Design Momentum (DM) have announced a strategic partnership to develop scientific instruments and laboratory equipment for life... Read More
-
Healx fights rare disorder via new global alliance
Healx, the AI-powered technology business repurposing drugs to fight rare diseases, has forged a new global alliance that could hold significant... Read More
-
Eagle in rudest of health after tie-up with hygiene specialist
UK-based global health and hygiene company RB is collaborating with Eagle Genomics in Cambridge in a research project designed to simplify... Read More
-
Cambridge startup inspires AI-led approach to cancer trials
Cambridge Cancer Genomics is leveraging its AI platform in a new partnership designed to more accurately target tumours in precision clinical trials... Read More
-
Arecor targets oncology and rare orphan diseases in US alliance
Cambridge biopharma business Arecor has extended its multi-product collaboration with a US-based clinical stage biotechnology company. Under the... Read More
-
Italian pioneer works with TTP to boost global health diagnostics
Technology hothouse TTP is at the heart of a European initiative to revolutionise in vitro diagnostic medical device (IVD) technology to boost... Read More
-
Heart and Seoul as Avacta launches Korean JV
Cambridge based BioMedTech business Avacta Group has joined forces with Daewoong Pharmaceutical to establish a significant joint venture in South... Read More
-
Healx and Boehringer battle rare neurological diseases
Cambridge-based Healx and German powerhouse Boehringer Ingelheim have joined forces to identify indications related to rare neurological diseases... Read More